TG Therapeutics, Inc.
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituxima…
Biotechnology
US, New York [HQ]
Balance Sheet
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | - - | 18.00 | 15.00 | 22.00 | 48.00 | 86.00 | 113.00 | 54.00 | 97.00 | 83.00 | 163.00 | 625.00 | 379.00 | 193.00 | 329.00 | |
|
Current
|
- - | - - | 9.00 | 18.00 | 42.00 | 85.00 | 86.00 | 50.00 | 93.00 | 79.00 | 149.00 | 611.00 | 330.00 | 168.00 | 317.00 | |
| Cash And Equivalents | - - | - - | 9.00 | 16.00 | 40.00 | 55.00 | 55.00 | 25.00 | 56.00 | 41.00 | 112.00 | 553.00 | 298.00 | 102.00 | 92.00 | |
| Assets | - - | 18.00 | 15.00 | 22.00 | 48.00 | 86.00 | 113.00 | 54.00 | 97.00 | 83.00 | 163.00 | 625.00 | 379.00 | 193.00 | 329.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -1.00 | 1.00 | -51.00 | |
| Inventory | - - | - - | - - | - - | -3.00 | 6.00 | -16.00 | 5.00 | 7.00 | 9.00 | - - | - - | -23.00 | - - | 39.00 | |
| Short Term Investments | - - | - - | - - | - - | 4.00 | 23.00 | 22.00 | 19.00 | 27.00 | 26.00 | 27.00 | 51.00 | 15.00 | 59.00 | 124.00 | |
| Other Current Assets | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 2.00 | 6.00 | 9.00 | |
|
Non Current
|
- - | 17.00 | 6.00 | 3.00 | 5.00 | 1.00 | 26.00 | 3.00 | 4.00 | 4.00 | 13.00 | 13.00 | 48.00 | 25.00 | 11.00 | |
| Property, Plant, Equipment (Net) | - - | - - | - - | - - | - - | - - | - - | 2.00 | 2.00 | 2.00 | 11.00 | 11.00 | 11.00 | 10.00 | 8.00 | |
|
Intangible Assets
|
- - | - - | 5.00 | 2.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | 4.00 | -22.00 | 25.00 | - - | - - | 1.00 | 1.00 | 1.00 | 35.00 | 12.00 | 1.00 | |
| Other Non Current Assets | - - | 17.00 | 438.00 | -10.00 | - - | - - | - - | - - | - - | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Liabilities | 7.00 | 23.00 | 6.00 | 6.00 | 48.00 | 86.00 | 113.00 | 54.00 | 97.00 | 59.00 | 124.00 | 106.00 | 142.00 | 134.00 | 169.00 | |
|
Current
|
2.00 | 3.00 | 1.00 | 2.00 | 6.00 | 5.00 | 10.00 | 16.00 | 27.00 | 38.00 | 84.00 | 87.00 | 65.00 | 53.00 | 53.00 | |
| Accounts Payable | - - | - - | - - | - - | 4.00 | - - | 5.00 | 6.00 | 11.00 | 10.00 | -4.00 | 11.00 | 15.00 | -11.00 | - - | |
| Short Term Debt | 1.00 | 2.00 | - - | - - | - - | - - | - - | - - | - - | - - | 1.00 | 23.00 | 2.00 | 1.00 | 1.00 | |
| Deferred Revenue | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 47.00 | - - | - - | - - | - - | |
| Tax Payable | - - | - - | - - | -25.00 | - - | -55.00 | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Current Liabilities | - - | - - | - - | - - | - - | - - | - - | 1.00 | 1.00 | 2.00 | 5.00 | 26.00 | 62.00 | 9.00 | 13.00 | |
|
Non Current
|
4.00 | 20.00 | 4.00 | 4.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 20.00 | 39.00 | 18.00 | 77.00 | 81.00 | 115.00 | |
| Long Term Debt | - - | 16.00 | 4.00 | 2.00 | - - | - - | - - | - - | - - | - - | 39.00 | 18.00 | 76.00 | 81.00 | 100.00 | |
| Leasing Obligations | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | 11.00 | 12.00 | 11.00 | 11.00 | 9.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | -2.00 | 3.00 | - - | - - | - - | - - | - - | 28.00 | 7.00 | -67.00 | -71.00 | -96.00 | |
| Other Non Current Liabilities | 3.00 | 3.00 | - - | 2.00 | -3.00 | - - | - - | - - | 1.00 | 19.00 | -28.00 | -7.00 | 67.00 | 71.00 | 106.00 | |
| Equity | -6.00 | -5.00 | 9.00 | 15.00 | 40.00 | 80.00 | 101.00 | 35.00 | 66.00 | 24.00 | -701.00 | 519.00 | -1,328.00 | -1,527.00 | 160.00 | |
| Stockholders' Equity | -6.00 | -5.00 | 9.00 | 15.00 | 40.00 | 80.00 | 101.00 | 35.00 | 66.00 | 24.00 | -701.00 | 519.00 | -1,328.00 | -1,527.00 | 160.00 | |
| Retained Earnings | -61.00 | -61.00 | - - | -18.00 | -39.00 | -95.00 | -158.00 | -236.00 | -354.00 | -528.00 | -701.00 | -980.00 | -1,328.00 | -1,527.00 | -1,514.00 | |
| Common Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Profit | -2.00 | - - | - - | -18.00 | -20.00 | -55.00 | -62.00 | -78.00 | -118.00 | -173.00 | -179.00 | -285.00 | -355.00 | -203.00 | 12.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | 55.00 | 55.00 | 10.00 | 34.00 | 79.00 | 175.00 | 259.00 | 272.00 | 421.00 | 552.00 | - - | 1,499.00 | - - | - - | 1,674.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - |